Cell therapy startup Myeloid narrows focus as staff shrinksnews2025-04-15T01:38:14+00:00April 15th, 2025|Endpoints News|
Trump drug tariffs inch closer as Commerce Department launches 232 investigationnews2025-04-14T22:27:27+00:00April 14th, 2025|Endpoints News|
Bristol Myers says Camzyos fails Phase 3 study in genetic heart conditionnews2025-04-14T21:40:57+00:00April 14th, 2025|Endpoints News|
CDC vaccine advisors set to meet this week after two-month delaynews2025-04-14T19:39:55+00:00April 14th, 2025|Endpoints News|
Primate researchers gird for funding cuts as NIH fights court blocknews2025-04-14T15:00:31+00:00April 14th, 2025|Endpoints News|
Verve unveils early data from second attempt at heart disease gene editingnews2025-04-14T11:00:35+00:00April 14th, 2025|Endpoints News|
In a blow to its obesity pipeline, Pfizer drops danuglipron after liver injury casenews2025-04-14T10:45:02+00:00April 14th, 2025|Endpoints News|
FDA unveils plan to replace animal testing with organoidsnews2025-04-11T19:41:07+00:00April 11th, 2025|Endpoints News|
Bristol Myers’ immunotherapy combo nets two new approvalsnews2025-04-11T17:36:43+00:00April 11th, 2025|Endpoints News|
Tome Bio founders wrangle ‘jumping genes’ for new gene insertion toolnews2025-04-11T11:00:40+00:00April 11th, 2025|Endpoints News|
